Lack of Benefit for Liraglutide in Heart Failure

JAMA. 2016 Dec 13;316(22):2429. doi: 10.1001/jama.2016.15387.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy
  • Glucagon-Like Peptide 1 / therapeutic use
  • Heart Failure / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Liraglutide*

Substances

  • Hypoglycemic Agents
  • Liraglutide
  • Glucagon-Like Peptide 1